Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On November 13, 2023, Harrow released its third quarter 2023 financial results, revising 2023 financial guidance due in part to the “compounding business underperform[ing] during the period.” The Company further released GAAP EPS and revenue figures that missed analyst estimates. Following this news, the price of the Company’s stock dropped.
Ticker Symbol | Company Name | Join Deadline | |
---|---|---|---|
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
NVO | Novo Nordisk A/S | March 25, 2025 | Join |
GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
NEM | Newmont Corporation | April 01, 2025 | Join |
GSK | GSK plc | April 07, 2025 | Join |
NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
MRK | Merck & Co., Inc. | April 14, 2025 | Join |